340B Drug Discount Program

Selected disproportionate share hospitals (DSH hospitals) and other qualifying entities are eligible for the 340B Drug Discount Program—a unique pharmaceutical discount opportunity that provides access to outpatient pharmaceuticals at very attractive pricing. For a typical hospital, the benefits can amount to more than $2 million. Yet, many eligible hospitals do not take advantage of this Program, and those that do participate often fail to maximize the benefits available to them.

Significant cost savings, and more.

Most participating hospitals focus exclusively on achieving cost reduction through the Program's attractive pharmaceutical prices. In fact, direct cost reduction potential can be significant—at a minimum, 20 percent of a hospital's outpatient drug spend, and often much higher.

But the most successful organizations gain even more. They view the 340B Drug Discount Program as a strategic opportunity with revenue, cost, compliance and other benefits.

The Claro Group helps eligible hospitals to implement and expand their use of 340B Drug Discount Program. Our services include developing and designing then implementing and sustaining a variety of creative opportunities to achieve:

• Increased patient access to pharmaceuticals.
• Increased financial benefits for the hospital.
• Enhanced compliance with the Program rules and regulations.

The Claro Group offers eligible hospitals many important differences from wholesalers and others in the market. We offer:

• Independence from a hospital's current practices and supply base.
• Focus on compliance with the Program rules and regulations.
• Experience with, and knowledge of, the AMDP process to facilitate many creative alternatives.
• Experience assisting hundreds of hospitals with change management related to staff and patient education needs.
• Incentives that are aligned with your hospital.

Please contact us for more information about The Claro Group's Healthcare Provider Solutions.